Effect of iron supplementation during early pregnancy on the development of gestational hypertension and pre-eclampsia
To investigate the association between iron supplementation during early pregnancy and the presence of de novo hypertension after 20 weeks’ gestation (either gestational hypertension or pre-eclampsia).
Retrospective cohort study.
This study retrospectively reviewed the medical records of non-anemic pregnant women who received first antenatal care at the Department of Obstetrics and Gynecology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand, during the June 2009–December 2010 study period. All included women had blood pressure and urine albumin level data that were recorded at each antenatal visit. The study population was divided into one of the two following groups: iron supplementation starting at gestational age (GA) < 16 weeks (study group) or GA ≥ 16 weeks (control group). A comparison of the proportion of de novo hypertension arising after 20 weeks’ gestation was then performed between groups.
Four hundred non-anemic pregnant women were included, with 200 patients allocated to each groups. The overall incidence of de novo hypertension after 20 weeks’ gestation was 10% (40/400), with significantly higher prevalence in the study group than that in the control group [13.5% (27/200) vs. 6.5% (13/200); relative risk: 2.14, 95%, CI 1.22–3.73; p = 0.008]. None of the women in this study developed anemia at time of delivery. There was no significant difference between groups for GA at delivery, birth weight, or birth asphyxia.
In our study population, iron supplementation before 16 weeks’ GA was significantly associated with increased risk of developing de novo hypertension after 20 weeks’ gestation.
KeywordsThai Iron supplementation Early pregnancy Pre-eclampsia Gestational hypertension
PJ: project development, data collection, data analysis, and manuscript writing. SS: project development, manuscript editing, and others (Supervisor). CR: project development and data analysis. KT: manuscript editing. BW: project development and data collection.
This was an unfunded study.
Compliance with ethical standards
Conflict of interest
All the authors declare no personal or professional conflicts of interest, and no financial support from the companies that produce and/or distribute the drugs, devices, or materials described in this report.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Hospital Institutional Review Board and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Statement of human rights
The present study was the retrospective study. All data were collected from previous hospital record.
For this type of study formal consent for participation is not required.
- 1.Brown MA, Magee LA, Kenny LC, Anath Karumanchi S, McCarthy FP, Saito S et al (2018) The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. https://doi.org/10.1016/j.preghy.2018.05.004 CrossRefPubMedGoogle Scholar
- 7.World Health Organization (2016) WHO recommendations on antenatal care for a positive pregnancy experience. World Health Organization, Geneva. https://www.ncbi.nlm.nih.gov/books/NBK409108/. Accessed 15 Jan 2017
- 17.Pena-Rosas JP, De-Regil LM, Garcia-Casal MN (2015) Dowswell T (2015) Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev 7:CD004736Google Scholar